EDEM2 anticorps (N-Term)
Aperçu rapide pour EDEM2 anticorps (N-Term) (ABIN5672922)
Antigène
Voir toutes EDEM2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- PLGLLCALLP QHHGAPGPDG SAPDPAHYRE RVKAMFYHAY DSYLENAFPF
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human EDEM2
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
-
Autre désignation
- EDEM2
-
Sujet
-
In the endoplasmic reticulum (ER), misfolded proteins are retrotranslocated to the cytosol and degraded by the proteasome in a process known as ER-associated degradation (ERAD). EDEM2 belongs to a family of proteins involved in ERAD of glycoproteins.
Alias Symbols: C20orf31, C20orf49, bA4204.1
Protein Size: 541 -
ID gène
- 55741
-
NCBI Accession
- NM_001145025, NP_001138497
Antigène
-